Author Page for Francesc Català-Moll

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Downloads 220 (346,707)

Citation 1

2

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 28 Aug 2024

Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Vicenç Falcó, Pere Domingo, Daniel Podzamczer, Lluís Force, Adrià Curran, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes

Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department

Downloads 142 (518,518)

Abstract:

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 05 Sep 2024

Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Adrià Curran, Pere Domingo, Daniel Podzamczer, Lluís Force, Vicenç Falcó, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes

Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department

Downloads 78 (826,467)

Citation 1

Abstract:

2.

Vitamin D Receptor, STAT3 and TET2 Cooperate to Establish Tolerogenesis

Number of pages: 42 Posted: 01 Jul 2021

Francesc Català-Moll, Anna G. Ferreté-Bonastre, Gerard Godoy-Tena, Octavio Morante-Palacios, Laura Ciudad, Laura Barberà, Federico Fondelli, Eva Martínez-Cáceres, Javier Rodríguez-Ubreva, Tianlu Li and Esteban Ballestar

Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Germans Trias i Pujol Research Institute (IGTP) - Division of Immunology, Germans Trias i Pujol Research Institute (IGTP) - Division of Immunology, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group and Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group

Downloads 32 (1,290,922)

Francesc Català-Moll

Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group

2

252

1

Scholarly Papers (2)

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Abstract:

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Abstract:

Vitamin D Receptor, STAT3 and TET2 Cooperate to Establish Tolerogenesis

Abstract: